KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Community Health Systems (CYH) Gains from Sales and Divestitures (2016 - 2026)

Community Health Systems has reported Gains from Sales and Divestitures over the past 17 years, most recently at $1.8 million for Q1 2026.

  • Quarterly Gains from Sales and Divestitures rose 15.51% to $1.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Mar 2026, up 15.51% year-over-year, with the annual reading at $255892.0 for FY2025, 88.43% down from the prior year.
  • Gains from Sales and Divestitures was $1.8 million for Q1 2026 at Community Health Systems, up from $255892.0 in the prior quarter.
  • Over five years, Gains from Sales and Divestitures peaked at $2.5 million in Q1 2022 and troughed at $4001.0 in Q3 2023.
  • The 5-year median for Gains from Sales and Divestitures is $129384.0 (2024), against an average of $736265.3.
  • Peak annual rise in Gains from Sales and Divestitures hit 1332.94% in 2023, while the deepest fall reached 96.2% in 2023.
  • Tracing CYH's Gains from Sales and Divestitures over 5 years: stood at $151058.0 in 2022, then surged by 1332.94% to $2.2 million in 2023, then rose by 2.19% to $2.2 million in 2024, then tumbled by 88.43% to $255892.0 in 2025, then soared by 614.58% to $1.8 million in 2026.
  • According to Business Quant data, Gains from Sales and Divestitures over the past three periods came in at $1.8 million, $255892.0, and $5894.0 for Q1 2026, Q4 2025, and Q2 2025 respectively.